prof. dr. Guy Brusselle
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Guy.Brusselle@UGent.be
- ORCID iD
-
0000-0001-7021-8505
Show
Sort by
-
NO in de uitgeademde lucht, een overzicht
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry
-
Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease : a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial
-
ERS statement : a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
-
Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease : a cross-sectional analysis of ten population-based studies
-
Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap
-
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes